APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,551,785 | -15.7% | 145,946 | +46.2% | 0.00% | -33.3% |
| Q2 2023 | $6,583,072 | 0.0% | 99,804 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $6,583,072 | +69.5% | 99,804 | +32.9% | 0.00% | +50.0% |
| Q4 2022 | $3,882,696 | -99.9% | 75,086 | +8.6% | 0.00% | -33.3% |
| Q3 2022 | $4,723,491,000 | -70.3% | 69,158 | -80.3% | 0.00% | -62.5% |
| Q2 2022 | $15,900,438,000 | -19.8% | 351,624 | -9.9% | 0.01% | 0.0% |
| Q1 2022 | $19,823,015,000 | +12.2% | 390,140 | +4.4% | 0.01% | +14.3% |
| Q4 2021 | $17,667,306,000 | +162.8% | 373,674 | +83.2% | 0.01% | +133.3% |
| Q3 2021 | $6,723,511,000 | -49.9% | 203,990 | -4.0% | 0.00% | -50.0% |
| Q2 2021 | $13,430,948,000 | +456.4% | 212,515 | +277.7% | 0.01% | +500.0% |
| Q1 2021 | $2,414,073,000 | -35.0% | 56,259 | -13.4% | 0.00% | -50.0% |
| Q4 2020 | $3,714,970,000 | +84.2% | 64,947 | -2.9% | 0.00% | +100.0% |
| Q3 2020 | $2,017,014,000 | -5.6% | 66,855 | +2.2% | 0.00% | 0.0% |
| Q2 2020 | $2,136,749,000 | +69.6% | 65,424 | +39.1% | 0.00% | 0.0% |
| Q1 2020 | $1,260,228,000 | +13.2% | 47,041 | +29.4% | 0.00% | 0.0% |
| Q4 2019 | $1,113,068,000 | +43.4% | 36,351 | +12.8% | 0.00% | 0.0% |
| Q3 2019 | $776,132,000 | +119.9% | 32,218 | +131.4% | 0.00% | – |
| Q2 2019 | $352,885,000 | – | 13,926 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |